Literature DB >> 21455536

Synthetic approaches for the conjugation of porphyrins and related macrocycles to peptides and proteins.

Francesca Giuntini1, Cristina M A Alonso, Ross W Boyle.   

Abstract

The association of photosensitisers to peptides and proteins is a recognised and successful method for enhancing the selectivity and efficacy of photodynamic treatment. The covalent attachment of porphyrins and related macrocycles to peptides and proteins can generate new phototoxic species that allow the concentration of the oxidative damage to the target area, thanks to their enhanced cellular uptake, favourable sub-cellular distribution, and ability to target receptors or enzymes over-expressed by a given tissue or cell. The need to exert control over the regioselectivity of the conjugation led to the exploration of a variety of chemistries; in some cases based on bioorthogonal ligations, in others exploring the reactivity of naturally occurring functional groups. In this review we place a major emphasis on the synthetic strategies adopted to generate such conjugates. All such strategies will be surveyed, together with the methods used to introduce or unmask the appropriate reactive functionalities both on the peptide moiety and the photosensitiser.

Mesh:

Substances:

Year:  2011        PMID: 21455536     DOI: 10.1039/c0pp00366b

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  16 in total

1.  Bioconjugatable, PEGylated Hydroporphyrins for Photochemistry and Photomedicine. Narrow-Band, Red-Emitting Chlorins.

Authors:  Mengran Liu; Chih-Yuan Chen; Amit Kumar Mandal; Vanampally Chandrashaker; Rosemary B Evans-Storms; J Bruce Pitner; David F Bocian; Dewey Holten; Jonathan S Lindsey
Journal:  New J Chem       Date:  2016-07-21       Impact factor: 3.591

2.  The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice.

Authors:  Valentina Rapozzi; Sonia Zorzet; Marina Zacchigna; Sara Drioli; Luigi E Xodo
Journal:  Invest New Drugs       Date:  2012-06-12       Impact factor: 3.850

Review 3.  Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.

Authors:  Nela Malatesti; Ivana Munitic; Igor Jurak
Journal:  Biophys Rev       Date:  2017-03-24

4.  Syntheses and cellular investigations of di-aspartate and aspartate-lysine chlorin e(6) conjugates.

Authors:  R G Waruna Jinadasa; Zehua Zhou; M Graça H Vicente; Kevin M Smith
Journal:  Org Biomol Chem       Date:  2015-12-03       Impact factor: 3.876

5.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

6.  Flexible synthesis of cationic peptide-porphyrin derivatives for light-triggered drug delivery and photodynamic therapy.

Authors:  R Dondi; E Yaghini; K M Tewari; L Wang; F Giuntini; M Loizidou; A J MacRobert; I M Eggleston
Journal:  Org Biomol Chem       Date:  2016-12-07       Impact factor: 3.876

Review 7.  Anticancer nanoparticulate polymer-drug conjugate.

Authors:  Quanyou Feng; Rong Tong
Journal:  Bioeng Transl Med       Date:  2016-10-28

8.  Tetraphenylporphyrin as a protein label for triple detection analytical systems.

Authors:  Kamila Konopińska; Mariusz Pietrzak; Radosław Mazur; Elżbieta Malinowska
Journal:  Heliyon       Date:  2015-12-22

9.  Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis.

Authors:  Fiona M Frame; Huguette Savoie; Francesca Bryden; Francesca Giuntini; Vincent M Mann; Matthew S Simms; Ross W Boyle; Norman J Maitland
Journal:  Cancer Med       Date:  2015-11-21       Impact factor: 4.452

10.  Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines.

Authors:  Elnaz Yaghini; Ruggero Dondi; Kunal M Tewari; Marilena Loizidou; Ian M Eggleston; Alexander J MacRobert
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.